Infectious Disease Point of Care Diagnostics Market, Global Outlook and Forecast 2022-2028
Point-of-care diagnosis is a test performed on the site of patient care that provides immediate results.Infectious diseases are caused by various microorganisms, such as viruses, bacteria, fungi and parasites.Instant diagnosis of infectious diseases can improve disease management and detection, reducing the time between disease testing and diagnosis of infection.It also reduces postoperative care time, improves outcomes, improves accuracy of outcomes, and provides a simple way to diagnose infectious diseases, broadly reducing the risk of HIV, tuberculosis, influenza, tropical diseases, and sexually transmitted infections.
This report contains market size and forecasts of Infectious Disease Point of Care Diagnostics in Global, including the following market information:
Global Infectious Disease Point of Care Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Infectious Disease Point of Care Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Over-the-counter (OTC) Testing Kits Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Infectious Disease Point of Care Diagnostics include Abbott, Siemens, GE Healthcare, Accriva, Terumo, BioMerieux, Diasorin, Roche and Danaher Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Infectious Disease Point of Care Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infectious Disease Point of Care Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Infectious Disease Point of Care Diagnostics Market Segment Percentages, by Type, 2021 (%)
Global Infectious Disease Point of Care Diagnostics Market Segment Percentages, by Application, 2021 (%)
Global Infectious Disease Point of Care Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Infectious Disease Point of Care Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Infectious Disease Point of Care Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Infectious Disease Point of Care Diagnostics in Global, including the following market information:
Global Infectious Disease Point of Care Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Infectious Disease Point of Care Diagnostics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Over-the-counter (OTC) Testing Kits Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Infectious Disease Point of Care Diagnostics include Abbott, Siemens, GE Healthcare, Accriva, Terumo, BioMerieux, Diasorin, Roche and Danaher Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Infectious Disease Point of Care Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infectious Disease Point of Care Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Infectious Disease Point of Care Diagnostics Market Segment Percentages, by Type, 2021 (%)
- Over-the-counter (OTC) Testing Kits
- Prescription-based Testing Kits
Global Infectious Disease Point of Care Diagnostics Market Segment Percentages, by Application, 2021 (%)
- Bacterial Infections
- Fungal Infection
- Virus Infection
- Cardiovascular Infection
- Gastrointestinal Infection
- Sexually Transmitted Disease (STD) Infection
- Central Nervous System Infection
- Other
Global Infectious Disease Point of Care Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Infectious Disease Point of Care Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Infectious Disease Point of Care Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott
- Siemens
- GE Healthcare
- Accriva
- Terumo
- BioMerieux
- Diasorin
- Roche
- Danaher Corporation
- BD
- Bio-Rad Laboratories
- Cavidi
- Cepheid
- Diaxonhit
- Eiken Chemical
- EMD Millipore
- Epitope Diagnostic
- Euroimmun
- Gold Standard Diagnostics
- Hologic
- Immunetics
- InBios International
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Infectious Disease Point of Care Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Infectious Disease Point of Care Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS OVERALL MARKET SIZE
2.1 Global Infectious Disease Point of Care Diagnostics Market Size: 2021 VS 2028
2.2 Global Infectious Disease Point of Care Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Infectious Disease Point of Care Diagnostics Players in Global Market
3.2 Top Global Infectious Disease Point of Care Diagnostics Companies Ranked by Revenue
3.3 Global Infectious Disease Point of Care Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Infectious Disease Point of Care Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Infectious Disease Point of Care Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Infectious Disease Point of Care Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Infectious Disease Point of Care Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Infectious Disease Point of Care Diagnostics Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Infectious Disease Point of Care Diagnostics Market Size Markets, 2021 & 2028
4.1.2 Over-the-counter (OTC) Testing Kits
4.1.3 Prescription-based Testing Kits
4.2 By Type - Global Infectious Disease Point of Care Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Infectious Disease Point of Care Diagnostics Revenue, 2017-2022
4.2.2 By Type - Global Infectious Disease Point of Care Diagnostics Revenue, 2023-2028
4.2.3 By Type - Global Infectious Disease Point of Care Diagnostics Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Infectious Disease Point of Care Diagnostics Market Size, 2021 & 2028
5.1.2 Bacterial Infections
5.1.3 Fungal Infection
5.1.4 Virus Infection
5.1.5 Cardiovascular Infection
5.1.6 Gastrointestinal Infection
5.1.7 Sexually Transmitted Disease (STD) Infection
5.1.8 Central Nervous System Infection
5.1.9 Other
5.2 By Application - Global Infectious Disease Point of Care Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Infectious Disease Point of Care Diagnostics Revenue, 2017-2022
5.2.2 By Application - Global Infectious Disease Point of Care Diagnostics Revenue, 2023-2028
5.2.3 By Application - Global Infectious Disease Point of Care Diagnostics Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Infectious Disease Point of Care Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Infectious Disease Point of Care Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Infectious Disease Point of Care Diagnostics Revenue, 2017-2022
6.2.2 By Region - Global Infectious Disease Point of Care Diagnostics Revenue, 2023-2028
6.2.3 By Region - Global Infectious Disease Point of Care Diagnostics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Infectious Disease Point of Care Diagnostics Revenue, 2017-2028
6.3.2 US Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.3.3 Canada Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.3.4 Mexico Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Infectious Disease Point of Care Diagnostics Revenue, 2017-2028
6.4.2 Germany Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.4.3 France Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.4.4 U.K. Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.4.5 Italy Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.4.6 Russia Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.4.7 Nordic Countries Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.4.8 Benelux Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Infectious Disease Point of Care Diagnostics Revenue, 2017-2028
6.5.2 China Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.5.3 Japan Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.5.4 South Korea Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.5.5 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.5.6 India Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Infectious Disease Point of Care Diagnostics Revenue, 2017-2028
6.6.2 Brazil Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.6.3 Argentina Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue, 2017-2028
6.7.2 Turkey Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.7.3 Israel Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.7.4 Saudi Arabia Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.7.5 UAE Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Infectious Disease Point of Care Diagnostics Major Product Offerings
7.1.4 Abbott Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.1.5 Abbott Key News
7.2 Siemens
7.2.1 Siemens Corporate Summary
7.2.2 Siemens Business Overview
7.2.3 Siemens Infectious Disease Point of Care Diagnostics Major Product Offerings
7.2.4 Siemens Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.2.5 Siemens Key News
7.3 GE Healthcare
7.3.1 GE Healthcare Corporate Summary
7.3.2 GE Healthcare Business Overview
7.3.3 GE Healthcare Infectious Disease Point of Care Diagnostics Major Product Offerings
7.3.4 GE Healthcare Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.3.5 GE Healthcare Key News
7.4 Accriva
7.4.1 Accriva Corporate Summary
7.4.2 Accriva Business Overview
7.4.3 Accriva Infectious Disease Point of Care Diagnostics Major Product Offerings
7.4.4 Accriva Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.4.5 Accriva Key News
7.5 Terumo
7.5.1 Terumo Corporate Summary
7.5.2 Terumo Business Overview
7.5.3 Terumo Infectious Disease Point of Care Diagnostics Major Product Offerings
7.5.4 Terumo Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.5.5 Terumo Key News
7.6 BioMerieux
7.6.1 BioMerieux Corporate Summary
7.6.2 BioMerieux Business Overview
7.6.3 BioMerieux Infectious Disease Point of Care Diagnostics Major Product Offerings
7.6.4 BioMerieux Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.6.5 BioMerieux Key News
7.7 Diasorin
7.7.1 Diasorin Corporate Summary
7.7.2 Diasorin Business Overview
7.7.3 Diasorin Infectious Disease Point of Care Diagnostics Major Product Offerings
7.7.4 Diasorin Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.7.5 Diasorin Key News
7.8 Roche
7.8.1 Roche Corporate Summary
7.8.2 Roche Business Overview
7.8.3 Roche Infectious Disease Point of Care Diagnostics Major Product Offerings
7.8.4 Roche Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.8.5 Roche Key News
7.9 Danaher Corporation
7.9.1 Danaher Corporation Corporate Summary
7.9.2 Danaher Corporation Business Overview
7.9.3 Danaher Corporation Infectious Disease Point of Care Diagnostics Major Product Offerings
7.9.4 Danaher Corporation Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.9.5 Danaher Corporation Key News
7.10 BD
7.10.1 BD Corporate Summary
7.10.2 BD Business Overview
7.10.3 BD Infectious Disease Point of Care Diagnostics Major Product Offerings
7.10.4 BD Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.10.5 BD Key News
7.11 Bio-Rad Laboratories
7.11.1 Bio-Rad Laboratories Corporate Summary
7.11.2 Bio-Rad Laboratories Business Overview
7.11.3 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Major Product Offerings
7.11.4 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.11.5 Bio-Rad Laboratories Key News
7.12 Cavidi
7.12.1 Cavidi Corporate Summary
7.12.2 Cavidi Business Overview
7.12.3 Cavidi Infectious Disease Point of Care Diagnostics Major Product Offerings
7.12.4 Cavidi Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.12.5 Cavidi Key News
7.13 Cepheid
7.13.1 Cepheid Corporate Summary
7.13.2 Cepheid Business Overview
7.13.3 Cepheid Infectious Disease Point of Care Diagnostics Major Product Offerings
7.13.4 Cepheid Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.13.5 Cepheid Key News
7.14 Diaxonhit
7.14.1 Diaxonhit Corporate Summary
7.14.2 Diaxonhit Business Overview
7.14.3 Diaxonhit Infectious Disease Point of Care Diagnostics Major Product Offerings
7.14.4 Diaxonhit Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.14.5 Diaxonhit Key News
7.15 Eiken Chemical
7.15.1 Eiken Chemical Corporate Summary
7.15.2 Eiken Chemical Business Overview
7.15.3 Eiken Chemical Infectious Disease Point of Care Diagnostics Major Product Offerings
7.15.4 Eiken Chemical Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.15.5 Eiken Chemical Key News
7.16 EMD Millipore
7.16.1 EMD Millipore Corporate Summary
7.16.2 EMD Millipore Business Overview
7.16.3 EMD Millipore Infectious Disease Point of Care Diagnostics Major Product Offerings
7.16.4 EMD Millipore Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.16.5 EMD Millipore Key News
7.17 Epitope Diagnostic
7.17.1 Epitope Diagnostic Corporate Summary
7.17.2 Epitope Diagnostic Business Overview
7.17.3 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Major Product Offerings
7.17.4 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.17.5 Epitope Diagnostic Key News
7.18 Euroimmun
7.18.1 Euroimmun Corporate Summary
7.18.2 Euroimmun Business Overview
7.18.3 Euroimmun Infectious Disease Point of Care Diagnostics Major Product Offerings
7.18.4 Euroimmun Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.18.5 Euroimmun Key News
7.19 Gold Standard Diagnostics
7.19.1 Gold Standard Diagnostics Corporate Summary
7.19.2 Gold Standard Diagnostics Business Overview
7.19.3 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Major Product Offerings
7.19.4 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.19.5 Gold Standard Diagnostics Key News
7.20 Hologic
7.20.1 Hologic Corporate Summary
7.20.2 Hologic Business Overview
7.20.3 Hologic Infectious Disease Point of Care Diagnostics Major Product Offerings
7.20.4 Hologic Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.20.5 Hologic Key News
7.21 Immunetics
7.21.1 Immunetics Corporate Summary
7.21.2 Immunetics Business Overview
7.21.3 Immunetics Infectious Disease Point of Care Diagnostics Major Product Offerings
7.21.4 Immunetics Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.21.5 Immunetics Key News
7.22 InBios International
7.22.1 InBios International Corporate Summary
7.22.2 InBios International Business Overview
7.22.3 InBios International Infectious Disease Point of Care Diagnostics Major Product Offerings
7.22.4 InBios International Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.22.5 InBios International Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Infectious Disease Point of Care Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Infectious Disease Point of Care Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL INFECTIOUS DISEASE POINT OF CARE DIAGNOSTICS OVERALL MARKET SIZE
2.1 Global Infectious Disease Point of Care Diagnostics Market Size: 2021 VS 2028
2.2 Global Infectious Disease Point of Care Diagnostics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Infectious Disease Point of Care Diagnostics Players in Global Market
3.2 Top Global Infectious Disease Point of Care Diagnostics Companies Ranked by Revenue
3.3 Global Infectious Disease Point of Care Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Infectious Disease Point of Care Diagnostics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Infectious Disease Point of Care Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Infectious Disease Point of Care Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Infectious Disease Point of Care Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Infectious Disease Point of Care Diagnostics Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Infectious Disease Point of Care Diagnostics Market Size Markets, 2021 & 2028
4.1.2 Over-the-counter (OTC) Testing Kits
4.1.3 Prescription-based Testing Kits
4.2 By Type - Global Infectious Disease Point of Care Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Infectious Disease Point of Care Diagnostics Revenue, 2017-2022
4.2.2 By Type - Global Infectious Disease Point of Care Diagnostics Revenue, 2023-2028
4.2.3 By Type - Global Infectious Disease Point of Care Diagnostics Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Infectious Disease Point of Care Diagnostics Market Size, 2021 & 2028
5.1.2 Bacterial Infections
5.1.3 Fungal Infection
5.1.4 Virus Infection
5.1.5 Cardiovascular Infection
5.1.6 Gastrointestinal Infection
5.1.7 Sexually Transmitted Disease (STD) Infection
5.1.8 Central Nervous System Infection
5.1.9 Other
5.2 By Application - Global Infectious Disease Point of Care Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Infectious Disease Point of Care Diagnostics Revenue, 2017-2022
5.2.2 By Application - Global Infectious Disease Point of Care Diagnostics Revenue, 2023-2028
5.2.3 By Application - Global Infectious Disease Point of Care Diagnostics Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Infectious Disease Point of Care Diagnostics Market Size, 2021 & 2028
6.2 By Region - Global Infectious Disease Point of Care Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Infectious Disease Point of Care Diagnostics Revenue, 2017-2022
6.2.2 By Region - Global Infectious Disease Point of Care Diagnostics Revenue, 2023-2028
6.2.3 By Region - Global Infectious Disease Point of Care Diagnostics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Infectious Disease Point of Care Diagnostics Revenue, 2017-2028
6.3.2 US Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.3.3 Canada Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.3.4 Mexico Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Infectious Disease Point of Care Diagnostics Revenue, 2017-2028
6.4.2 Germany Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.4.3 France Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.4.4 U.K. Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.4.5 Italy Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.4.6 Russia Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.4.7 Nordic Countries Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.4.8 Benelux Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Infectious Disease Point of Care Diagnostics Revenue, 2017-2028
6.5.2 China Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.5.3 Japan Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.5.4 South Korea Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.5.5 Southeast Asia Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.5.6 India Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Infectious Disease Point of Care Diagnostics Revenue, 2017-2028
6.6.2 Brazil Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.6.3 Argentina Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue, 2017-2028
6.7.2 Turkey Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.7.3 Israel Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.7.4 Saudi Arabia Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
6.7.5 UAE Infectious Disease Point of Care Diagnostics Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Abbott
7.1.1 Abbott Corporate Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Infectious Disease Point of Care Diagnostics Major Product Offerings
7.1.4 Abbott Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.1.5 Abbott Key News
7.2 Siemens
7.2.1 Siemens Corporate Summary
7.2.2 Siemens Business Overview
7.2.3 Siemens Infectious Disease Point of Care Diagnostics Major Product Offerings
7.2.4 Siemens Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.2.5 Siemens Key News
7.3 GE Healthcare
7.3.1 GE Healthcare Corporate Summary
7.3.2 GE Healthcare Business Overview
7.3.3 GE Healthcare Infectious Disease Point of Care Diagnostics Major Product Offerings
7.3.4 GE Healthcare Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.3.5 GE Healthcare Key News
7.4 Accriva
7.4.1 Accriva Corporate Summary
7.4.2 Accriva Business Overview
7.4.3 Accriva Infectious Disease Point of Care Diagnostics Major Product Offerings
7.4.4 Accriva Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.4.5 Accriva Key News
7.5 Terumo
7.5.1 Terumo Corporate Summary
7.5.2 Terumo Business Overview
7.5.3 Terumo Infectious Disease Point of Care Diagnostics Major Product Offerings
7.5.4 Terumo Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.5.5 Terumo Key News
7.6 BioMerieux
7.6.1 BioMerieux Corporate Summary
7.6.2 BioMerieux Business Overview
7.6.3 BioMerieux Infectious Disease Point of Care Diagnostics Major Product Offerings
7.6.4 BioMerieux Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.6.5 BioMerieux Key News
7.7 Diasorin
7.7.1 Diasorin Corporate Summary
7.7.2 Diasorin Business Overview
7.7.3 Diasorin Infectious Disease Point of Care Diagnostics Major Product Offerings
7.7.4 Diasorin Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.7.5 Diasorin Key News
7.8 Roche
7.8.1 Roche Corporate Summary
7.8.2 Roche Business Overview
7.8.3 Roche Infectious Disease Point of Care Diagnostics Major Product Offerings
7.8.4 Roche Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.8.5 Roche Key News
7.9 Danaher Corporation
7.9.1 Danaher Corporation Corporate Summary
7.9.2 Danaher Corporation Business Overview
7.9.3 Danaher Corporation Infectious Disease Point of Care Diagnostics Major Product Offerings
7.9.4 Danaher Corporation Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.9.5 Danaher Corporation Key News
7.10 BD
7.10.1 BD Corporate Summary
7.10.2 BD Business Overview
7.10.3 BD Infectious Disease Point of Care Diagnostics Major Product Offerings
7.10.4 BD Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.10.5 BD Key News
7.11 Bio-Rad Laboratories
7.11.1 Bio-Rad Laboratories Corporate Summary
7.11.2 Bio-Rad Laboratories Business Overview
7.11.3 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Major Product Offerings
7.11.4 Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.11.5 Bio-Rad Laboratories Key News
7.12 Cavidi
7.12.1 Cavidi Corporate Summary
7.12.2 Cavidi Business Overview
7.12.3 Cavidi Infectious Disease Point of Care Diagnostics Major Product Offerings
7.12.4 Cavidi Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.12.5 Cavidi Key News
7.13 Cepheid
7.13.1 Cepheid Corporate Summary
7.13.2 Cepheid Business Overview
7.13.3 Cepheid Infectious Disease Point of Care Diagnostics Major Product Offerings
7.13.4 Cepheid Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.13.5 Cepheid Key News
7.14 Diaxonhit
7.14.1 Diaxonhit Corporate Summary
7.14.2 Diaxonhit Business Overview
7.14.3 Diaxonhit Infectious Disease Point of Care Diagnostics Major Product Offerings
7.14.4 Diaxonhit Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.14.5 Diaxonhit Key News
7.15 Eiken Chemical
7.15.1 Eiken Chemical Corporate Summary
7.15.2 Eiken Chemical Business Overview
7.15.3 Eiken Chemical Infectious Disease Point of Care Diagnostics Major Product Offerings
7.15.4 Eiken Chemical Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.15.5 Eiken Chemical Key News
7.16 EMD Millipore
7.16.1 EMD Millipore Corporate Summary
7.16.2 EMD Millipore Business Overview
7.16.3 EMD Millipore Infectious Disease Point of Care Diagnostics Major Product Offerings
7.16.4 EMD Millipore Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.16.5 EMD Millipore Key News
7.17 Epitope Diagnostic
7.17.1 Epitope Diagnostic Corporate Summary
7.17.2 Epitope Diagnostic Business Overview
7.17.3 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Major Product Offerings
7.17.4 Epitope Diagnostic Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.17.5 Epitope Diagnostic Key News
7.18 Euroimmun
7.18.1 Euroimmun Corporate Summary
7.18.2 Euroimmun Business Overview
7.18.3 Euroimmun Infectious Disease Point of Care Diagnostics Major Product Offerings
7.18.4 Euroimmun Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.18.5 Euroimmun Key News
7.19 Gold Standard Diagnostics
7.19.1 Gold Standard Diagnostics Corporate Summary
7.19.2 Gold Standard Diagnostics Business Overview
7.19.3 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Major Product Offerings
7.19.4 Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.19.5 Gold Standard Diagnostics Key News
7.20 Hologic
7.20.1 Hologic Corporate Summary
7.20.2 Hologic Business Overview
7.20.3 Hologic Infectious Disease Point of Care Diagnostics Major Product Offerings
7.20.4 Hologic Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.20.5 Hologic Key News
7.21 Immunetics
7.21.1 Immunetics Corporate Summary
7.21.2 Immunetics Business Overview
7.21.3 Immunetics Infectious Disease Point of Care Diagnostics Major Product Offerings
7.21.4 Immunetics Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.21.5 Immunetics Key News
7.22 InBios International
7.22.1 InBios International Corporate Summary
7.22.2 InBios International Business Overview
7.22.3 InBios International Infectious Disease Point of Care Diagnostics Major Product Offerings
7.22.4 InBios International Infectious Disease Point of Care Diagnostics Revenue in Global Market (2017-2022)
7.22.5 InBios International Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Infectious Disease Point of Care Diagnostics Market Opportunities & Trends in Global Market
Table 2. Infectious Disease Point of Care Diagnostics Market Drivers in Global Market
Table 3. Infectious Disease Point of Care Diagnostics Market Restraints in Global Market
Table 4. Key Players of Infectious Disease Point of Care Diagnostics in Global Market
Table 5. Top Infectious Disease Point of Care Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Infectious Disease Point of Care Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Infectious Disease Point of Care Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Infectious Disease Point of Care Diagnostics Product Type
Table 9. List of Global Tier 1 Infectious Disease Point of Care Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Infectious Disease Point of Care Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Infectious Disease Point of Care Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Infectious Disease Point of Care Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Infectious Disease Point of Care Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Infectious Disease Point of Care Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Infectious Disease Point of Care Diagnostics Product Offerings
Table 32. Abbott Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Siemens Corporate Summary
Table 34. Siemens Infectious Disease Point of Care Diagnostics Product Offerings
Table 35. Siemens Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. GE Healthcare Corporate Summary
Table 37. GE Healthcare Infectious Disease Point of Care Diagnostics Product Offerings
Table 38. GE Healthcare Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Accriva Corporate Summary
Table 40. Accriva Infectious Disease Point of Care Diagnostics Product Offerings
Table 41. Accriva Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. Terumo Corporate Summary
Table 43. Terumo Infectious Disease Point of Care Diagnostics Product Offerings
Table 44. Terumo Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. BioMerieux Corporate Summary
Table 46. BioMerieux Infectious Disease Point of Care Diagnostics Product Offerings
Table 47. BioMerieux Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. Diasorin Corporate Summary
Table 49. Diasorin Infectious Disease Point of Care Diagnostics Product Offerings
Table 50. Diasorin Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. Roche Corporate Summary
Table 52. Roche Infectious Disease Point of Care Diagnostics Product Offerings
Table 53. Roche Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. Danaher Corporation Corporate Summary
Table 55. Danaher Corporation Infectious Disease Point of Care Diagnostics Product Offerings
Table 56. Danaher Corporation Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 57. BD Corporate Summary
Table 58. BD Infectious Disease Point of Care Diagnostics Product Offerings
Table 59. BD Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 60. Bio-Rad Laboratories Corporate Summary
Table 61. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Product Offerings
Table 62. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 63. Cavidi Corporate Summary
Table 64. Cavidi Infectious Disease Point of Care Diagnostics Product Offerings
Table 65. Cavidi Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 66. Cepheid Corporate Summary
Table 67. Cepheid Infectious Disease Point of Care Diagnostics Product Offerings
Table 68. Cepheid Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 69. Diaxonhit Corporate Summary
Table 70. Diaxonhit Infectious Disease Point of Care Diagnostics Product Offerings
Table 71. Diaxonhit Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 72. Eiken Chemical Corporate Summary
Table 73. Eiken Chemical Infectious Disease Point of Care Diagnostics Product Offerings
Table 74. Eiken Chemical Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 75. EMD Millipore Corporate Summary
Table 76. EMD Millipore Infectious Disease Point of Care Diagnostics Product Offerings
Table 77. EMD Millipore Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 78. Epitope Diagnostic Corporate Summary
Table 79. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Product Offerings
Table 80. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 81. Euroimmun Corporate Summary
Table 82. Euroimmun Infectious Disease Point of Care Diagnostics Product Offerings
Table 83. Euroimmun Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 84. Gold Standard Diagnostics Corporate Summary
Table 85. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Product Offerings
Table 86. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 87. Hologic Corporate Summary
Table 88. Hologic Infectious Disease Point of Care Diagnostics Product Offerings
Table 89. Hologic Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 90. Immunetics Corporate Summary
Table 91. Immunetics Infectious Disease Point of Care Diagnostics Product Offerings
Table 92. Immunetics Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 93. InBios International Corporate Summary
Table 94. InBios International Infectious Disease Point of Care Diagnostics Product Offerings
Table 95. InBios International Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 1. Infectious Disease Point of Care Diagnostics Market Opportunities & Trends in Global Market
Table 2. Infectious Disease Point of Care Diagnostics Market Drivers in Global Market
Table 3. Infectious Disease Point of Care Diagnostics Market Restraints in Global Market
Table 4. Key Players of Infectious Disease Point of Care Diagnostics in Global Market
Table 5. Top Infectious Disease Point of Care Diagnostics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Infectious Disease Point of Care Diagnostics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Infectious Disease Point of Care Diagnostics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Infectious Disease Point of Care Diagnostics Product Type
Table 9. List of Global Tier 1 Infectious Disease Point of Care Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Infectious Disease Point of Care Diagnostics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Infectious Disease Point of Care Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Infectious Disease Point of Care Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Infectious Disease Point of Care Diagnostics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Infectious Disease Point of Care Diagnostics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2023-2028
Table 30. Abbott Corporate Summary
Table 31. Abbott Infectious Disease Point of Care Diagnostics Product Offerings
Table 32. Abbott Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 33. Siemens Corporate Summary
Table 34. Siemens Infectious Disease Point of Care Diagnostics Product Offerings
Table 35. Siemens Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 36. GE Healthcare Corporate Summary
Table 37. GE Healthcare Infectious Disease Point of Care Diagnostics Product Offerings
Table 38. GE Healthcare Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 39. Accriva Corporate Summary
Table 40. Accriva Infectious Disease Point of Care Diagnostics Product Offerings
Table 41. Accriva Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 42. Terumo Corporate Summary
Table 43. Terumo Infectious Disease Point of Care Diagnostics Product Offerings
Table 44. Terumo Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 45. BioMerieux Corporate Summary
Table 46. BioMerieux Infectious Disease Point of Care Diagnostics Product Offerings
Table 47. BioMerieux Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 48. Diasorin Corporate Summary
Table 49. Diasorin Infectious Disease Point of Care Diagnostics Product Offerings
Table 50. Diasorin Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 51. Roche Corporate Summary
Table 52. Roche Infectious Disease Point of Care Diagnostics Product Offerings
Table 53. Roche Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 54. Danaher Corporation Corporate Summary
Table 55. Danaher Corporation Infectious Disease Point of Care Diagnostics Product Offerings
Table 56. Danaher Corporation Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 57. BD Corporate Summary
Table 58. BD Infectious Disease Point of Care Diagnostics Product Offerings
Table 59. BD Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 60. Bio-Rad Laboratories Corporate Summary
Table 61. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Product Offerings
Table 62. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 63. Cavidi Corporate Summary
Table 64. Cavidi Infectious Disease Point of Care Diagnostics Product Offerings
Table 65. Cavidi Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 66. Cepheid Corporate Summary
Table 67. Cepheid Infectious Disease Point of Care Diagnostics Product Offerings
Table 68. Cepheid Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 69. Diaxonhit Corporate Summary
Table 70. Diaxonhit Infectious Disease Point of Care Diagnostics Product Offerings
Table 71. Diaxonhit Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 72. Eiken Chemical Corporate Summary
Table 73. Eiken Chemical Infectious Disease Point of Care Diagnostics Product Offerings
Table 74. Eiken Chemical Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 75. EMD Millipore Corporate Summary
Table 76. EMD Millipore Infectious Disease Point of Care Diagnostics Product Offerings
Table 77. EMD Millipore Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 78. Epitope Diagnostic Corporate Summary
Table 79. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Product Offerings
Table 80. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 81. Euroimmun Corporate Summary
Table 82. Euroimmun Infectious Disease Point of Care Diagnostics Product Offerings
Table 83. Euroimmun Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 84. Gold Standard Diagnostics Corporate Summary
Table 85. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Product Offerings
Table 86. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 87. Hologic Corporate Summary
Table 88. Hologic Infectious Disease Point of Care Diagnostics Product Offerings
Table 89. Hologic Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 90. Immunetics Corporate Summary
Table 91. Immunetics Infectious Disease Point of Care Diagnostics Product Offerings
Table 92. Immunetics Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
Table 93. InBios International Corporate Summary
Table 94. InBios International Infectious Disease Point of Care Diagnostics Product Offerings
Table 95. InBios International Infectious Disease Point of Care Diagnostics Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Infectious Disease Point of Care Diagnostics Segment by Type in 2021
Figure 2. Infectious Disease Point of Care Diagnostics Segment by Application in 2021
Figure 3. Global Infectious Disease Point of Care Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Infectious Disease Point of Care Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Infectious Disease Point of Care Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Infectious Disease Point of Care Diagnostics Revenue in 2021
Figure 8. By Type - Global Infectious Disease Point of Care Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Infectious Disease Point of Care Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Infectious Disease Point of Care Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Infectious Disease Point of Care Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Infectious Disease Point of Care Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Infectious Disease Point of Care Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Infectious Disease Point of Care Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Siemens Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GE Healthcare Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Accriva Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Terumo Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. BioMerieux Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Diasorin Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Roche Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Danaher Corporation Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. BD Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Cavidi Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Cepheid Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Diaxonhit Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Eiken Chemical Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. EMD Millipore Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Euroimmun Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Hologic Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Immunetics Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. InBios International Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Infectious Disease Point of Care Diagnostics Segment by Type in 2021
Figure 2. Infectious Disease Point of Care Diagnostics Segment by Application in 2021
Figure 3. Global Infectious Disease Point of Care Diagnostics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Infectious Disease Point of Care Diagnostics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Infectious Disease Point of Care Diagnostics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Infectious Disease Point of Care Diagnostics Revenue in 2021
Figure 8. By Type - Global Infectious Disease Point of Care Diagnostics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Infectious Disease Point of Care Diagnostics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Infectious Disease Point of Care Diagnostics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Infectious Disease Point of Care Diagnostics Revenue Market Share, 2017-2028
Figure 12. US Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Infectious Disease Point of Care Diagnostics Revenue Market Share, 2017-2028
Figure 16. Germany Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 17. France Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Infectious Disease Point of Care Diagnostics Revenue Market Share, 2017-2028
Figure 24. China Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 28. India Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Infectious Disease Point of Care Diagnostics Revenue Market Share, 2017-2028
Figure 30. Brazil Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Infectious Disease Point of Care Diagnostics Revenue Market Share, 2017-2028
Figure 33. Turkey Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Infectious Disease Point of Care Diagnostics Revenue, (US$, Mn), 2017-2028
Figure 37. Abbott Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Siemens Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. GE Healthcare Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Accriva Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Terumo Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. BioMerieux Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Diasorin Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Roche Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Danaher Corporation Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. BD Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Bio-Rad Laboratories Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Cavidi Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Cepheid Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Diaxonhit Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Eiken Chemical Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. EMD Millipore Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Epitope Diagnostic Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Euroimmun Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Gold Standard Diagnostics Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Hologic Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Immunetics Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. InBios International Infectious Disease Point of Care Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
